54535-00-1Relevant articles and documents
Imidazo[4,5-c]pyridine derivative and application thereof
-
Paragraph 0135; 0143; 0146; 0147, (2019/10/01)
The invention relates to a novel imidazo[4,5-c]pyridine derivative represented by a general formula I, and pharmaceutically acceptable salts, solvates or prodrugs of the novel imidazo[4,5-c]pyridine derivative, wherein the substituent R and R' are defined as in the specification. The invention also relates to an effect of the compound represented by the general formula I in inhibiting an NS5B RNA-dependent RNA polymerase (NS5B polymerase for short) which is necessary in a replication process of hepatitis c virus, also relates to an application of the compound, and pharmaceutically acceptable salts, hydrates or prodrugs of the compound in preparation of medicines for treating viral diseases, and especially relates to an application in preparation of medicines for treating and/or preventinghepatitis c.
IMIDAZOLE DERIVATIVES
-
Page/Page column 52, (2015/06/11)
The present invention relates to compounds of formula (I), wherein A, B, R1 and R2 are as defined herein before.
INHIBITORS OF HEPATITIS C VIRUS POLYMERASE
-
Page/Page column 102-103, (2012/06/30)
The present invention provides, among other things, compounds represented by the general Formula (I) and pharmaceutically acceptable salts thereof, wherein X, Y, R1A, R1B, R2, and R3 are as defined in classes and subclasses herein and compositions (e.g., pharmaceutical compositions) comprising such compounds, which compounds are useful as inhibitors of hepatitis C virus polymerase, and thus are useful, for example, as medicaments for the treatment of HCV infection.